Literature DB >> 14560103

Peptidoglycan and lipoteichoic acid in gram-positive bacterial sepsis: receptors, signal transduction, biological effects, and synergism.

Jacob E Wang1, Maria K Dahle, Michelle McDonald, Simon J Foster, Ansgar O Aasen, Christoph Thiemermann.   

Abstract

In sepsis and multiple organ dysfunction syndrome (MODS) caused by gram-negative bacteria, lipopolysaccharide (LPS) initiates the early signaling events leading to the deleterious inflammatory response. However, it has become clear that LPS can not reproduce all of the clinical features of sepsis, which emphasize the roles of other contributing factors. Gram-positive bacteria, which lack LPS, are today responsible for a substantial part of the incidents of sepsis with MODS. The major wall components of gram-positive bacteria, peptidoglycan and lipoteichoic acid, are thought to contribute to the development of sepsis and MODS. In this review, the literature underlying our current understanding of how peptidoglycan and lipoteichoic acid activate inflammatory responses will be presented, with a focus on recent advances in this field.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14560103     DOI: 10.1097/01.shk.0000092268.01859.0d

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  31 in total

Review 1.  The preterm parturition syndrome.

Authors:  R Romero; J Espinoza; J P Kusanovic; F Gotsch; S Hassan; O Erez; T Chaiworapongsa; M Mazor
Journal:  BJOG       Date:  2006-12       Impact factor: 6.531

Review 2.  The role of inflammation and infection in preterm birth.

Authors:  Roberto Romero; Jimmy Espinoza; Luís F Gonçalves; Juan Pedro Kusanovic; Lara Friel; Sonia Hassan
Journal:  Semin Reprod Med       Date:  2007-01       Impact factor: 1.303

Review 3.  Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target.

Authors:  Kenneth L Becker; Richard Snider; Eric S Nylen
Journal:  Br J Pharmacol       Date:  2009-11-27       Impact factor: 8.739

4.  Atrial natriuretic peptide protects against Staphylococcus aureus-induced lung injury and endothelial barrier dysfunction.

Authors:  Junjie Xing; Nurgul Moldobaeva; Anna A Birukova
Journal:  J Appl Physiol (1985)       Date:  2010-11-04

5.  Rac1 regulates bacterial toxin-induced thrombin generation.

Authors:  Yongzhi Wang; Rundk Hwaiz; Lingtao Luo; Oscar Ö Braun; Eva Norström; Henrik Thorlacius
Journal:  Inflamm Res       Date:  2016-02-12       Impact factor: 4.575

6.  Vigorous, but differential mononuclear cell response of cirrhotic patients to bacterial ligands.

Authors:  Varenka J Barbero-Becerra; María Concepción Gutiérrez-Ruiz; Carmen Maldonado-Bernal; Félix I Téllez-Avila; Roberto Alfaro-Lara; Florencia Vargas-Vorácková
Journal:  World J Gastroenterol       Date:  2011-03-14       Impact factor: 5.742

7.  Structural basis of recognition of pathogen-associated molecular patterns and inhibition of proinflammatory cytokines by camel peptidoglycan recognition protein.

Authors:  Pradeep Sharma; Divya Dube; Amar Singh; Biswajit Mishra; Nagendra Singh; Mau Sinha; Sharmistha Dey; Punit Kaur; Dipendra K Mitra; Sujata Sharma; Tej P Singh
Journal:  J Biol Chem       Date:  2011-03-21       Impact factor: 5.157

Review 8.  Role of LPS-elicited signaling in triggering gastric mucosal inflammatory responses to H. pylori: modulatory effect of ghrelin.

Authors:  B L Slomiany; A Slomiany
Journal:  Inflammopharmacology       Date:  2017-05-17       Impact factor: 4.473

9.  Bacterial flagellin elicits widespread innate immune defense mechanisms, apoptotic signaling, and a sepsis-like systemic inflammatory response in mice.

Authors:  Joëlle Rolli; Noureddine Loukili; Sandra Levrand; Nathalie Rosenblatt-Velin; Stéphanie Rignault-Clerc; Bernard Waeber; François Feihl; Pal Pacher; Lucas Liaudet
Journal:  Crit Care       Date:  2010-08-24       Impact factor: 9.097

10.  TLR4 genetic variation is associated with inflammatory responses in Gram-positive sepsis.

Authors:  N Chantratita; S Tandhavanant; S Seal; C Wikraiphat; G Wongsuvan; P Ariyaprasert; P Suntornsut; N Teerawattanasook; Y Jutrakul; N Srisurat; P Chaimanee; W Mahavanakul; P Srisamang; S Phiphitaporn; M Mokchai; J Anukunananchai; S Wongratanacheewin; P Chetchotisakd; M J Emond; S J Peacock; T E West
Journal:  Clin Microbiol Infect       Date:  2016-09-08       Impact factor: 8.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.